Features of interaction of complexes cortisol-apolipoprotein A-I and tetrahydrocortisol-apolipoprotein A-I with eukariotic DNA

被引:0
|
作者
Panin, LE [1 ]
Tuzikov, FV
Tuzikova, NA
Polyakov, LM
机构
[1] Russian Acad Sci, Siberian Div, Inst Biochem, Novosibirsk 630117, Russia
[2] Minist Publ Hlth Russian Federat, Vector State Res Ctr Virol & Biotechnol, Koltsov 630559, Novosibirsk Reg, Russia
关键词
hepatocytes; synthesis DNA and protein; secondary structure DNA; oligonuclcleotides; cortisol; tetrahydrocortisol; apolipoprotein A-I; small-angle X-ray scattering;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
On primary culture of hepatocytes it is shown, that a complex cortisol-apolipoprotein A-I did not change rate of biosynthesis DNA and protein, whereas the complex tetrahydrocortisol-apolipoprotein A-I (THC-apoA-I) essentially raised rate of incorporation 3 H-thymidine in DNA and C-14-leucine into protein. By a method of small-angle X-ray scattering it is shown, that appreciable interaction with eukariotic DNA is marked only in case of use of a complex THC-apoA-I, thus there is local fusion of DNA. The most probable region of interaction of the given complex with DNA is repetition (GCC)(n) the type, included in structure of many genes eukariot, including the human. It is synthesized oligonucleotid (duplex) of this type. It is shown, that at his interaction with complex THC-apoA-I there is a formation of more difficult complex, which breaks up with formation of complementary chains of oligonucleotides. The last also enter interaction with complex THC-apoA-I. It is given of kinetic this multiphasic process. Interaction of a complex cortisol-anoA-I with a duplex is less specific and does not result reduce in decay of the duplex and in formation of complementary oligonucleotides.
引用
下载
收藏
页码:300 / 309
页数:10
相关论文
共 50 条
  • [41] Apolipoprotein A-I is a molecular lariat
    Segrest, JP
    Harvey, S
    Jones, MK
    CIRCULATION, 1998, 98 (17) : 2 - 2
  • [42] PHOSPHORYLATION OF HUMAN APOLIPOPROTEIN A-I
    BEG, ZH
    STONIK, JA
    HOEG, JM
    DEMOSKY, SJ
    BREWER, HB
    CIRCULATION, 1987, 76 (04) : 117 - 117
  • [43] Apolipoprotein A-I mimetic peptides
    Anantharamaiah, GM
    Navab, M
    Reddy, ST
    Hama, S
    Hough, G
    Palgunachari, MN
    Datta, G
    Garber, DW
    Fogelman, AM
    BIOPOLYMERS, 2005, 80 (04) : 498 - 498
  • [44] HUMAN APOLIPOPROTEIN A-I DEFICIENCY
    Schaefer, E.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [45] Effect of glucocorticoids and their complexes with apolipoprotein A-I on the secondary structure of eukaryotic DNA
    Panin, LE
    Kunitsyn, VG
    Tusikov, FV
    INTERNATIONAL JOURNAL OF QUANTUM CHEMISTRY, 2005, 101 (04) : 450 - 467
  • [46] Domain structure and lipid interaction in human apolipoprotein A-I
    Saito, H
    Lund-Katz, S
    Phillips, MC
    ATHEROSCLEROSIS SUPPLEMENTS, 2003, 4 (02) : 221 - 221
  • [47] Opposite regulation of human versus mouse apolipoprotein A-I by fibrates in human apolipoprotein A-I transgenic mice
    Berthou, L
    Duverger, N
    Emmanuel, F
    Langouet, S
    Auwerx, J
    Guillouzo, A
    Fruchart, JC
    Rubin, E
    Denefle, P
    Staels, B
    Branellec, D
    JOURNAL OF CLINICAL INVESTIGATION, 1996, 97 (11): : 2408 - 2416
  • [48] Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal
    Navab, M
    Anantharamaiah, GM
    Reddy, ST
    Van Lenten, BJ
    Datta, G
    Garber, D
    Fogelman, AM
    CURRENT OPINION IN LIPIDOLOGY, 2004, 15 (06) : 645 - 649
  • [49] RAT APOLIPOPROTEIN A-I (A-I) EPITOPE EXPRESSION IS INFLUENCED BY LIPID ENVIRONMENT
    RICHMOND, JF
    WALSH, MT
    GLASS, C
    ATKINSON, D
    ARTERIOSCLEROSIS, 1988, 8 (05): : A604 - A605
  • [50] Apolipoprotein A-I and risk for cardiovascular diseases
    Khuseyinova N.
    Koenig W.
    Current Atherosclerosis Reports, 2006, 8 (5) : 365 - 373